Skip to content

Evaluation of Efficacy and Safety of Goff Transpancreatic Septotomy vs. Double Wire Technique for Achieving Biliary Access in Technically Challenging ERCPs

Evaluation of Efficacy and Safety of Goff Transpancreatic Septotomy vs. Double Wire Technique for Achieving Biliary Access in Technically Challenging ERCPs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03118973
Enrollment
1600
Registered
2017-04-18
Start date
2016-09-27
Completion date
2020-01-01
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Obstruction, Biliary Stones

Brief summary

Randomized, prospective study evaluating efficacy and safety of Goff transpancreatic septotomy vs. double wire technique for achieving biliary access in patients who fail initial cannulation at ERCP.

Detailed description

Selective placement of a guidewire into the bile duct (biliary cannulation) during endoscopic retrograde cholangiopancreatography (ERCP) is necessary for performing therapeutic biliary procedures. The success rate for biliary cannulation by experienced endoscopists during ERCP is approximately 85% with standard cannulation techniques. Inadvertent placement of the guidewire into the pancreatic duct rather than the bile duct often occurs when attempting selective biliary cannulation in technically challenging cases. When this occurs repeatedly, other approaches may be used to facilitate selective biliary cannulation, but there are few prospective studies evaluating the efficacy and safety of these approaches. Here the investigators evaluate two approaches for technically challenging biliary cannulation: one involving maintenance of a wire in the pancreatic duct, followed by repeat attempt at biliary cannulation (double wire technique) and one involving a small incision in the septum adjacent to the pancreas followed by repeat attempt at biliary cannulation (transpancreatic septotomy). This study is a prospective randomized trial comparing the rate of cannulation success, procedure duration and complications following these two approaches.

Interventions

PROCEDUREGoff trans-pancreatic septotomy vs. Double wire technique

Goff trans-pancreatic septotomy vs. Double wire technique for achieving biliary access when biliary cannulation is challenging.

Sponsors

Subhas Banerjee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients with challenging biliary cannulation randomized to either Goff trans-pancreatic septotomy or double wire technique to facilitate biliary cannulation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 and older 2. Patient has a clinical indication for ERCP 3. Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

1. Age \<18 2. Potentially vulnerable subjects including, homeless people, pregnant females, employees and students. 3. Complex post-surgical anatomy e.g. Billroth type II anatomy, Roux-en-Y-gastrojejunostomy 4. Prior sphincterotomy or balloon dilation of ampulla 5. Thrombocytopenia, coagulopathy, or indication for ongoing anti-coagulation therapy 6. Participation in another investigational study that may directly or indirectly affect the results of this study within 30 days prior to the initial visit

Design outcomes

Primary

MeasureTime frameDescription
Successful biliary cannulation assessed by fluoroscopic confirmation of biliary cannulationDay of procedureSuccessful biliary cannulation

Secondary

MeasureTime frameDescription
Adverse event rates assessed by 6-month follow-up of clinical and laboratory studies6 monthsRates of adverse events associated with the ERCP procedure following intervention to facilitate biliary cannulation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026